Protein Kinase A Activity Controls the Regulation of T-type CaV3.2 Channels by Gβγ DimersS

Low voltage-activated (LVA), T-type, calcium channels mediate diverse biological functions and are inhibited by Gβγ dimers, yet the molecular events required for channel inhibition remain unknown. Here, we identify protein kinase A (PKA) as a molecular switch that allows Gβ 2 γx dimers to effect vol...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 284; no. 12; pp. 7465 - 7473
Main Authors Hu, Changlong, DePuy, Seth D., Yao, Junlan, McIntire, William E., Barrett, Paula Q.
Format Journal Article
LanguageEnglish
Published American Society for Biochemistry and Molecular Biology 20.03.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Low voltage-activated (LVA), T-type, calcium channels mediate diverse biological functions and are inhibited by Gβγ dimers, yet the molecular events required for channel inhibition remain unknown. Here, we identify protein kinase A (PKA) as a molecular switch that allows Gβ 2 γx dimers to effect voltage-independent inhibition of Ca v 3.2 channels. Inhibition requires phosphorylation of Ser 1107 , a critical serine residue on the II-III loop of the channel pore protein. S1107A prevents inhibition of unitary currents by recombinant Gβ 2 γ 2 dimers but does not disrupt dimer binding nor change its specificity. Gβγ dimers released upon receptor activation also require PKA activity for their inhibitory actions. Hence, dopamine inhibition of Ca v 3.2 whole cell current is precluded by Gβγ-scavenger proteins or a peptide that blocks PKA catalytic activity. Fittingly, when used alone at receptor-selective concentrations, D 1 or D 2 agonists do not elicit channel inhibition yet together synergize to inhibit Ca v 3.2 channel currents. We propose that a dual-receptor regulatory mechanism is used by dopamine to control Ca v 3.2 channel activity. This mechanism, for example, would be important in aldosterone producing adrenal glomerulosa cells where channel dysregulation would lead to overproduction of aldosterone and consequent cardiac, renal, and brain target organ damage.
Bibliography:To whom correspondence should be addressed: 1300 Jefferson Park Ave, Charlottesville, VA 22908. Fax: 434-982-3878; E-mail: pqb4b@virginia.edu.
This work was supported, in whole or in part, by National Institutes of Health Grant HL36977 (to P. Q. B.). This work was also supported by American Heart Association Grant AHA 053535ON (to W. E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a postdoctoral fellowship from the American Heart Association Mid-Atlantic Affiliate.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M808049200